More than 80 million people in Europe are affected, and many more are undiagnosed, with primary care practitioners ill-prepared to identify the conditions.

Newly released Medicare national coverage determinations are set to reshape the home ventilation landscape for chronic ...

Chronic respiratory illnesses affect millions. Learn how PCPs can effectively manage asthma, COPD, and allergies through ...

Clarametyx Biosciences has received approval from the Independent DMC to progress its Phase Ib/IIa trial of CMTX-101 ...

Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study. The study ...

Lupin partners with SUP to commercialize Tiotropium DPI in China, aiming to improve respiratory health with innovative products.